The IPO Buzz: Mineralys Therapeutics Up Nearly 32 Percent in NASDAQ Debut
Happy Friday! Hypertension biotech Mineralys Therapeutics, Inc. (MLYS) opened at $21.10 – up 31.9 percent from its $16.00 IPO price – at 11:15 a.m. EST today (Friday, Feb. 10, 2023) on the NASDAQ. And just like that, Mineralys Therapeutics scored the best opening gain of the three big IPOs priced this week. In comparison, solar […]
February 10, 2023 Read More